Header Logo

Connection

MILIND JAVLE to Republic of Korea

Back to Details
This is a "connection" page, showing publications MILIND JAVLE has written about Republic of Korea.
MILIND JAVLE
Connection Strength
0.046
Republic of Korea
  1. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2020 06; 21(6):796-807.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.